163 related articles for article (PubMed ID: 37482742)
21. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
23. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
[TBL] [Abstract][Full Text] [Related]
24. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
[TBL] [Abstract][Full Text] [Related]
25. Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy.
Long S; Chen Y; Wang Y; Yao Y; Xiao S; Fu K
Cancer Med; 2023 Jan; 12(2):2134-2147. PubMed ID: 35841206
[TBL] [Abstract][Full Text] [Related]
26. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
27. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
28. Integrative bioinformatics and experimental analysis revealed TEAD as novel prognostic target for hepatocellular carcinoma and its roles in ferroptosis regulation.
Ren X; Wang X; Yan Y; Chen X; Cai Y; Liang Q; Peng B; Xu Z; He Q; Kang F; Li J; Zhang W; Hong Q; Peng J; Xiao M
Aging (Albany NY); 2022 Jan; 14(2):961-974. PubMed ID: 35077390
[TBL] [Abstract][Full Text] [Related]
29. Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma.
Li C; Cui X; Li Y; Guo D; He S
Sci Rep; 2023 May; 13(1):8681. PubMed ID: 37248280
[TBL] [Abstract][Full Text] [Related]
30. [EHHADH is a key gene in fatty acid metabolism pathways in hepatocellular carcinoma: a transcriptomic analysis].
Xie S; Li M; Jiang F; Yi Q; Yang W
Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):680-693. PubMed ID: 37313808
[TBL] [Abstract][Full Text] [Related]
31. Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells.
Yu MM; Feng YH; Zheng L; Zhang J; Luo GH
World J Gastroenterol; 2019 Mar; 25(10):1210-1223. PubMed ID: 30886504
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Analysis of Epigenetic Associated Genes on Differential Gene Expression and Prognosis in Hepatocellular Carcinoma.
Li C; Ding J; Mei J
J Environ Pathol Toxicol Oncol; 2022; 41(1):27-43. PubMed ID: 35378002
[TBL] [Abstract][Full Text] [Related]
33. ZNF8-miR-552-5p Axis Modulates ACSL4-Mediated Ferroptosis in Hepatocellular Carcinoma.
Yang H; Sun W; Bi T; Sun J; Lu Z; Li J; Wei H
DNA Cell Biol; 2023 Jun; 42(6):336-347. PubMed ID: 37126948
[TBL] [Abstract][Full Text] [Related]
34. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
[TBL] [Abstract][Full Text] [Related]
35. Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma.
Zeng Z; Jiang X; Pan Z; Zhou R; Lin Z; Tang Y; Cui Y; Zhang E; Cao Z
Aging (Albany NY); 2021 Oct; 13(19):22802-22829. PubMed ID: 34607313
[TBL] [Abstract][Full Text] [Related]
36. [Study on mechanism of icariin-induced ferroptosis in HepG2 hepatoma carcinoma cells through PPARG/FABP4/GPX4 pathway].
Li L; Zeng PH; Yang RY; Deng Y; He ZM; Xia X; Zhu DY; Peng QH
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1295-1309. PubMed ID: 38621977
[TBL] [Abstract][Full Text] [Related]
37. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
38.
Chen M; Wang D; Liu J; Zhou Z; Ding Z; Liu L; Su D; Li H
Biomed Res Int; 2020; 2020():3280530. PubMed ID: 32964027
[TBL] [Abstract][Full Text] [Related]
39. Identification and validation of ferroptosis-related prognostic risk model and immune landscape in hepatocellular carcinoma.
Tang F; Wang N
Immunobiology; 2023 Sep; 228(5):152723. PubMed ID: 37517112
[TBL] [Abstract][Full Text] [Related]
40. Identify an innovative ferroptosis-related gene in hepatocellular carcinoma.
Hu G; Huang X; Zhang B; Gao P; Wu W; Wang J
J Clin Lab Anal; 2022 Sep; 36(9):e24632. PubMed ID: 35908779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
